Mednax Gross Profit vs. EBITDA
| MD Stock | USD 14.76 0.20 1.34% |
Gross Profit | First Reported 1994-03-31 | Previous Quarter 105.3 M | Current Value 116.8 M | Quarterly Volatility 81.7 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.2 | 0.2113 |
|
| |||||
| Operating Profit Margin | 0.0035 | 0.0037 |
|
|
For Mednax profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Mednax to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Mednax Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Mednax's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Mednax Inc over time as well as its relative position and ranking within its peers.
Mednax |
Mednax's Revenue Breakdown by Earning Segment
Check out Correlation Analysis.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Earnings Share (2.34) | Revenue Per Share 24.174 | Quarterly Revenue Growth 0.009 | Return On Assets 0.0467 |
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mednax Inc EBITDA vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Mednax's current stock value. Our valuation model uses many indicators to compare Mednax value to that of its competitors to determine the firm's financial worth. Mednax Inc is regarded fifth in gross profit category among its peers. It is rated below average in ebitda category among its peers totaling about 0.06 of EBITDA per Gross Profit. The ratio of Gross Profit to EBITDA for Mednax Inc is roughly 15.63 . At present, Mednax's Gross Profit is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Mednax by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Mednax EBITDA vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Mednax |
| = | 467.03 M |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Mednax |
| = | 29.89 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Mednax EBITDA Comparison
Mednax is currently under evaluation in ebitda category among its peers.
Mednax Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Mednax, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Mednax will eventually generate negative long term returns. The profitability progress is the general direction of Mednax's change in net profit over the period of time. It can combine multiple indicators of Mednax, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -2.2 M | -2.3 M | |
| Operating Income | 7.3 M | 7 M | |
| Income Before Tax | -48.4 M | -45.9 M | |
| Total Other Income Expense Net | -55.7 M | -58.5 M | |
| Net Loss | -60.4 M | -57.4 M | |
| Income Tax Expense | 12 M | 11.4 M | |
| Net Income Applicable To Common Shares | 59.7 M | 48.1 M | |
| Net Loss | -60.4 M | -57.4 M | |
| Non Operating Income Net Other | -51 M | -48.5 M | |
| Interest Income | 39.4 M | 69.6 M | |
| Net Interest Income | -42.1 M | -44.2 M | |
| Change To Netincome | 36.1 M | 34.3 M | |
| Net Loss | (0.72) | (0.68) | |
| Income Quality | (2.27) | (2.16) | |
| Net Income Per E B T | 1.25 | 1.31 |
Mednax Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Mednax. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Mednax position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Mednax's important profitability drivers and their relationship over time.
Use Mednax in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mednax position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mednax will appreciate offsetting losses from the drop in the long position's value.Mednax Pair Trading
Mednax Inc Pair Trading Analysis
The ability to find closely correlated positions to Mednax could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mednax when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mednax - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mednax Inc to buy it.
The correlation of Mednax is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mednax moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mednax Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mednax can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Mednax position
In addition to having Mednax in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run FinTech Thematic Idea Now
FinTech
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The FinTech theme has 81 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize FinTech Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
To fully project Mednax's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Mednax Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Mednax's income statement, its balance sheet, and the statement of cash flows.